◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › DNA

Ginkgo Bioworks Holdings, Inc. (DNA) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-09

Ginkgo Bioworks Holdings, Inc. (DNA) operates in the Biotechnology industry and is headquartered in Boston, United States with about 485 employees. Its market capitalization is roughly $633 million. In the fiscal year ended 2025-12-31, DNA reported $170M in revenue and ($313M) in net income.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments.

Interactive charts & full statements → Open the DNA valuation workbench →

DNA Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$170M$227M$252M$478M
Gross Profit$123M$182M$197M$274M
Operating Income (EBIT)($304M)($488M)($768M)($2.2B)
Net Income($313M)($547M)($893M)($2.1B)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DNA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$20M$33M$39M$50M$38M
Gross Profit$16M$26M$26M$35M$34M
Operating Income (EBIT)($71M)($70M)($88M)($62M)($76M)
Net Income($83M)($81M)($81M)($60M)($91M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DNA Free Cash Flow History

DNA Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$1.1B$1.4B$1.7B$2.5B
Total Liabilities$611M$661M$568M$803M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DNA viewer.

Other Companies in Biotechnology

← DMRCAll stocksDNLI →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.